Regulatory Affairs in Clinical Research :-The task of regulatory affairs in industry ranges from the commencement of the novel product from development for human usage, registration with regulatory, market suitability and production optimization.
Regulatory affairs are relatively new proposition which developed from the wish of governments to safe guard public health by critically weighing the safety and efficacy of novel products in areas of pharmaceuticals and medical devices.
As industry has diverted its attention to global expansion for internationally suitable products, regulatory affairs have become a decisive conduit for communicating interdependencies of global and applicable regulatory bodies and their requirements. The need for internationally acceptable products intensifies the urgency for synchronization of regulatory requirements to provide efficiency and cost effectiveness to the practice of new product development, manufacturing and fitness to global admittance.
Biopharmaceutical companies are continuing to expand their frontiers to manage a global reach, with existence in many regions and nations, and therefore exposed to innumerable, and many a times diverse, regulatory demands and working standards.
These challenges equally support the vital role of the regulatory team and highlight the need for enhanced global regulatory need based interactions with regulatory professionals who are tough leaders, business associates and deliberate contributors.
The regulatory professional’s job is to keep an eye on the constantly changing legislations in all the countries in which the company desires to market its products. They also advise on the legal and scientific boundaries and obligations, and gather, compare and assess the scientific data their research and development contemporaries are generating.
James Lind Institute offers Clinical Research and Regulatory Affairs Training. If you wish to join Clinical 
Research and Regulatory Affairs Course please apply: